Project Orbis Archives -

Takeda has secured UK approval for its lung cancer therapy Exkivity, with an NHS access deal that could

NHS grants fast-track access to Takeda’s lung cancer drug Exkivity

https://pharmaphorum.com/news/nhs-grants-fast-track-access-to-takedas-lung-cancer-drug-exkivity/

Amgen’s first-in-class KRAS inhibitor Lumykras has been approved in Great Britain and arrives already armed with an agreement

NHS fast tracks access to Amgen’s just-approved KRAS cancer drug

https://pharmaphorum.com/news/nhs-fast-tracks-access-to-amgens-just-approved-kras-cancer-drug/

With a new year comes the opportunity to think ahead for the market access landscape for the coming

2021 – UK market access prospects

https://pharmaphorum.com/views-analysis-market-access/2021-uk-market-access-prospects/

Project Orbis